What is Arecor Therapeutics plc (AREC.L)?

Arecor Therapeutics plc (AREC.L) is a stock in the Healthcare sector, Biotechnology industry. View full analysis on Stocks360.

Arecor Therapeutics plc (AREC.L)

Stock analysis · LSE · Healthcare · Biotechnology

Market Cap

N/A

PE (TTM)

N/A

EPS (TTM)

N/A

Dividend Yield

N/A

Beta

-0.21

Day Range

N/A

52-wk Range

N/A

Avg Volume

N/A

Volume

N/A

Arecor Therapeutics plc (AREC.L) is a publicly traded company in the Healthcare sector. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

You have viewed 4 SEO analysis pages

Unlock saved watchlists, personalized setups, and referral credits with a free Stocks360 account.

Continue with free signup

Proprietary Signals

Signal snapshot temporarily unavailable.

About Arecor Therapeutics plc

Arecor Therapeutics PLC is a biopharmaceutical enterprise dedicated to creating therapies for diabetes and various other medical conditions. The company utilizes its exclusive Arestat formulation technology platform to both cultivate its own range of specialized products (for diabetes and other ailments) and collaborate with pharmaceutical and biotechnology partners to refine and enhance existing therapeutic formulations. Its pipeline includes AT247, an exceptionally fast-acting insulin aimed at individuals with Type I and Type II diabetes, and AT278, a highly concentrated rapid-acting insulin formulation engineered to hasten insulin absorption following injection. Established in 2007, the company's main office is situated in Little Chesterford, United Kingdom.